Top Markets
Coin of the day
Regen BioPharma, Inc. Regen BioPharma, Inc.

Regen BioPharma, Inc.

RGBP
Rang in Aktien #42223
Regen BioPharma, Inc. is a company dedicated to advancing regenerative medicine... Regen BioPharma, Inc. is a company dedicated to advancing regenerative medicine within the United States. It actively researches and identifies small molecule compounds designed to modulate the NR2F6 gene. This modulation is strategically aimed at activating immune cells for oncology treatments and suppressing them for autoimmune conditions. Its therapeutic pipeline and product development are currently in their initial phases. Established in 2012, the firm operates from its headquarters in La Mesa, California.
Aktienkurs
$0.0001
Marktkapitalisierung
$3.16K
Veränderung (1 Tag)
0.00%
Veränderung (1 Jahr)
-99.75%
Land
US
Handel Regen BioPharma, Inc. (RGBP)

Kategorie

Kursverlauf für Regen BioPharma, Inc. (RGBP)
Höchster Schlusskurs: $0.00 am 2026-08-01

Niedrigster Schlusskurs: $177.92 am 2014-09-01
Kursverlauf der Aktie von Regen BioPharma, Inc. von 2014 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2026 (TTM) -28.06%
2025 -88.47%
2024 -83.36%
2023 -85.13%
2022 -70.52%
2021 1,498.80%
2020 267.41%
2019 -93.59%
2018 -94.01%
2017 -23.18%
2016 -52.03%
2015 24.23%
2014 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
$527.87 36.13%
US
$873.57 37.02%
NL
$736.38 8.73%
CH
$263.09 20.45%
BE
$1.07K -5.56%
KR